Gartanin Protects Neurons Against Glutamate-Induced Cell Death in Ht22 Cells: Independence of Nrf-2 but Involvement of Ho-1 and Ampk

Xiao-yun Gao,Sheng-nan Wang,Xiao-hong Yang,Wen-jian Lan,Zi-wei Chen,Jing-kao Chen,Jian-hui Xie,Yi-fan Han,Rong-biao Pi,Xiao-bo Yang
DOI: https://doi.org/10.1007/s11064-016-1941-x
IF: 4.4
2016-01-01
Neurochemical Research
Abstract:Oxidative stress mediates the pathogenesis of neurodegenerative disorders. Gartanin, a natural xanthone of mangosteen, possesses multipharmacological activities. Herein, the neuroprotection capacity of gartanin against glutamate-induced damage in HT22 cells and its possible mechanism(s) were investigated for the first time. Glutamate resulted in cell death in a dose-dependent manner and supplementation of 1–10 µM gartanin prevented the detrimental effects of glutamate on cell survival. Additional investigations on the underlying mechanisms suggested that gartanin could effectively reduce glutamate-induced intracellular ROS generation and mitochondrial depolarization. We further found that gartanin induced HO-1 expression independent of nuclear factor erythroid-derived 2-like 2 (Nrf2). Subsequent studies revealed that the inhibitory effects of gartanin on glutamate-induced apoptosis were partially blocked by small interfering RNA-mediated knockdown of HO-1. Finally, the protein expression of phosphorylation of AMP-activated protein kinase (AMPK) and its downstream signal molecules, Sirtuin activator (SIRT1) and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), increased after gartanin treatment. Taken together, these findings suggest gartanin is a potential neuroprotective agent against glutamate-induced oxidative injury partially through increasing Nrf-2-independed HO-1 and AMPK/SIRT1/PGC-1α signaling pathways.
What problem does this paper attempt to address?